CLU and metastatic malignant neoplasm in the lymph nodes: PTC patients with lymph node metastasis showed significantly lower IHC scores for PROS1 (P < .001), CLU (P = .003), and LRG1 (P < .001) than patients without metastasis, respectively (Tables 4–6).